Skip to main content

Animations

MJFF Publications

8221 - 8230 of 8816 Results
Title
Year
  • Year
  • 2015
  • 2015
  • 2018
  • 2015
  • 2025
  • 2019
  • 2015
  • 2025
  • 2011
  • 2019
  • Summary Details
    OPEN
    Title: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus
    Journal Name: BioMed Research International
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2015/569052
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Enhanced histamine H2 excitation of striatal cholinergic interneurons in l-DOPA-induced dyskinesia
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.01.003
    Citation Count: 43
  • Summary Details
    OPEN
    Title: The deterministic role of 5-mers in microRNA-gene targeting
    Journal Name: RNA Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/15476286.2018.1462652
    Citation Count: 16
  • Summary Details
    RESTRICTED
    Title: Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2015.02.005
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Modelling cholinergic and dopaminergic function over time in Parkinson’s disease with and without GBA1 variants
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01160-3
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(18)30405-8
    Citation Count: 111
  • Summary Details
    RESTRICTED
    Title: Minimal change multiple system atrophy: An aggressive variant?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.26220
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Effect of the mGlu2 receptor positive allosteric modulator AZD8529 on L-DOPA-induced dyskinesia and psychosis-like behaviours in the parkinsonian marmoset
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2025.178031
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Serotonergic mediated body mass index changes in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2011.05.009
    Citation Count: 43
  • Summary Details
    RESTRICTED
    Title: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergy
    Journal Name: The Journal of Allergy and Clinical Immunology: In Practice
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.